candida, systemic infection, non-neutropenic patients
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2005 Oct 22-28;366(9495):1435-42 Randomized Controlled Trial, Multicenter Study
IN candida, systemic infection, non-neutropenic patients The Use of
voriconazole
As Treatment, Acute
Is equal Than
amphotericin B followed by oral fluconazole
To achieve a successful clinical and bacteriological outcome : 65% voriconazole VS 71% amphotericine; 95% CI for difference -10.6% to 10.6%. Dicontinuation by adverse effects equal to amphot.